Search - tctmd.com

Displaying 341 - 360 of 620

Sort: Relevancy | Date

Presentation CHIP Washington DC 2017

Status Update: The CHIP Initiative 2017

Presenter: Jeffrey W. Moses

March 16, 2017

Presentation SIF 2017

Advancing the Guidelines for Unprotected Left Main PCI

Presenter: David A. Cox

March 10, 2017

Presentation JIM 2017

Complete Percutaneous Revascularization in a Patient Refused for CABG

Presenter: Marco Ancona

February 11, 2017

Presentation JIM 2017

Distal LM Medina 1,1,1

Presenter: Robert-Jan van Geuns

February 10, 2017

Presentation JIM 2017

Hemodynamic Support for Complete Revascularization During the Most Complex Interventions

Presenter: Alaide Chieffo

February 10, 2017

Presentation JIM 2017

AngiosculptX Drug-coated PTCA Scoring Balloon: Findings from Pre-clinical and Clinical Experience

Presenter: Robert A. Byrne

February 10, 2017

Presentation JIM 2017

CTO and Multi Vessel Disease. The key to complete revascularization

Presenter: Simon Walsh

February 09, 2017

Presentation Miami Valves 2017

Case: 81 yo Male With Severe AS

Presenter: Marek Cena

January 29, 2017

Presentation Miami Valves 2017

Excimer Laser Coronary Angioplasty (ELCA) 25 Years Later What Have We Learned?

Presenter: James R. Margolis

January 29, 2017

Presentation Miami Valves 2017

Case: 84 you Male with Porcine AVR 15 years ago and Moderate AR

Presenter: Zubin Agarwal

January 29, 2017

Presentation CHIP Florida 2017

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Presenter: Tanveer Rab

January 21, 2017

Presentation CHIP Florida 2017

Key Initiatives in the CHIP Space: OPTUMUM, AUC, and More

Presenter: J. Aaron Grantham

January 21, 2017

Presentation CHIP Florida 2017

The Spectrum of Acute Mechanical Circulatory Support Devices in 2017

Presenter: Navin K. Kapur

January 21, 2017

Presentation CHIP Florida 2017

Multivessel Disease and Low EF Case

Presenter: Raja Hatem

January 21, 2017

Presentation CHIP Florida 2017

Left Main Intervention: EXCEL, NOBLE and Beyond…

Presenter: Jeffrey W. Moses

January 21, 2017

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

Presentation TCT 2016

Highlights (and my Interpretations) from: EXCEL and NOBLE

Presenter: Yves R. Louvard, John D. Puskas, Davide Capodanno

November 01, 2016

Presentation TCT 2016

Case Resolution: What Was Done

Presenter: John A. Bittl, David J. Maron, Kishore J. Harjai

November 01, 2016

Presentation TCT 2016

The Case for Surgery

Presenter: Michael A. Borger, Vinod H. Thourani, Martin Misfeld

November 01, 2016

Advertisement

Status Update: The CHIP Initiative 2017

Advancing the Guidelines for Unprotected Left Main PCI

Complete Percutaneous Revascularization in a Patient Refused for CABG

Distal LM Medina 1,1,1

Hemodynamic Support for Complete Revascularization During the Most Complex Interventions

AngiosculptX Drug-coated PTCA Scoring Balloon: Findings from Pre-clinical and Clinical Experience

CTO and Multi Vessel Disease. The key to complete revascularization

Case: 81 yo Male With Severe AS

Excimer Laser Coronary Angioplasty (ELCA) 25 Years Later What Have We Learned?

Case: 84 you Male with Porcine AVR 15 years ago and Moderate AR

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Key Initiatives in the CHIP Space: OPTUMUM, AUC, and More

The Spectrum of Acute Mechanical Circulatory Support Devices in 2017

Multivessel Disease and Low EF Case

Left Main Intervention: EXCEL, NOBLE and Beyond…

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Arterial Revascularization Trial (ART)

Highlights (and my Interpretations) from: EXCEL and NOBLE

Case Resolution: What Was Done

The Case for Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content